Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis

BACKGROUND: Dalfampridine has the potential to be effective in patients with transverse myelitis (TM) as this rare disorder shares some clinical and pathogenic similarities with multiple sclerosis. METHODS: This is a randomized, double-blind, placebo-controlled crossover study of dalfampridine exten...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Kateryna, Wymbs, Nicholas F, Huang, Hwa, Mealy, Maureen A, Pardo, Carlos A, Zackowski, Kathleen, Levy, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731631/
https://www.ncbi.nlm.nih.gov/pubmed/29270309
http://dx.doi.org/10.1177/2055217317740145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731631/
https://www.ncbi.nlm.nih.gov/pubmed/29270309
http://dx.doi.org/10.1177/2055217317740145

Ejemplares similares